A road less traveled paved by IDO silencing
暂无分享,去创建一个
[1] B. Blazar,et al. Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth. , 2012, Cancer research.
[2] J. Sampson,et al. Regulatory T Cells Move in When Gliomas Say “I DO” , 2012, Clinical Cancer Research.
[3] Atique U. Ahmed,et al. IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival , 2012, Clinical Cancer Research.
[4] R. Muschel,et al. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. , 2012, Critical reviews in oncology/hematology.
[5] M. Hensel,et al. Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors. , 2011, Cancer research.
[6] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[7] D. Munn,et al. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. , 2009, Blood.
[8] H. Kajiyama,et al. Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival , 2008, Clinical Cancer Research.
[9] C. MacKenzie,et al. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. , 2007, Current drug metabolism.
[10] P. Carey,et al. Neutrophil activation, vascular leak toxicity, and cytolysis during interleukin-2 infusion in human cancer. , 1997, Surgery.